Polypharmacy Among The Elderly In The City Of São Paulo, Brazil - Sabe Study [polifarmácia Entre Idosos Do Município De São Paulo - Estudo Sabe] by Carvalho M.F.C. et al.
817 Rev Bras Epidemiol2012; 15(4): 817-27
Polypharmacy among the 
elderly in the city of São Paulo, 
Brazil – SABE Study
Polifarmácia entre idosos do 
Município de São Paulo - Estudo 
SABE
Maristela Ferreira Catão CarvalhoI





Yeda Aparecida de Oliveira DuarteIV
I Instituto Paulista de Geriatria e Gerontologia José Ermírio de Moraes – SES/SP.
II Departamento de Prática de Saúde Pública da Faculdade de Saúde Pública da 
Universidade de São Paulo – USP.
III Departamento de Farmacologia da Faculdade de Ciências Médicas da 
Universidade Estadual de Campinas – UNICAMP.
IV Departamento de Enfermagem Médico Cirúrgica da Escola de Enfermagem 
da Universidade de São Paulo – USP.
V Departamento de Farmácia da Faculdade de Ciências Farmacêuticas da 
Universidade de São Paulo – USP.
VI Departamento de Epidemiologia da Faculdade de Saúde Pública da 
Universidade de São Paulo – USP.
Pesquisa financiada pela FAPESP – Processo 1999/05125-7.
Correspondência: Nicolina Silvana Romano Lieber. Departamento de Prática de Saúde, Faculdade 
de Saúde Pública, Universidade de São Paulo – USP. Av. Dr. Arnaldo, 715 – Cerqueira César, São 
Paulo, SP, Brasil CEP 01246-904. E-mail: nicolina@usp.br
Abstract
Polypharmacy for the elderly and associated 
factors were assessed. A cross-sectional 
study was conducted using data from the 
SABE Study (Health, Well-being and Aging), 
2006. 1,115 individuals representing 422,377 
elderly aged 65 or more, living in São Paulo 
City, were interviewed. Polypharmacy was 
defined as the use of five or more medica-
tions. A multivariate regression logistics was 
used. Polypharmacy prevalence was 36%. 
Female (OR = 1.7; IC 95%: 1.0; 2.9), age over 
75 years (OR = 1.9; CI 95%: 1.3; 2.7), higher 
income (OR = 1.8; CI 95%: 1.2; 2.8), working 
(OR = 1.8; CI 95%: 1.1; 2.9), regular self asses-
sed health (OR = 1.6; CI 95%: 1.1; 2.3) or poor 
(OR = 2.6; CI 95%: 1.4; 4.9), hypertension (OR 
= 2.0; CI 95%: 1.4; 2.9), diabetes (OR = 4.1; 
CI 95%: 2.2; 7.5), rheumatic diseases (OR = 
2.3; CI 95%: 1.5; 3.6) and cardiac problems 
(OR = 2.9; CI 95%: 1.9; 4.5) were associated 
positively with polypharmacy. Using only 
the public health system (OR = 0.5, 95% 
CI: 0.3; 0.7) was inversely associated with 
polypharmacy. Medicines for the cardio-
vascular system and for the alimentary 
tract and metabolism were the most used. 
The knowledge of factors associated with 
polypharmacy, such as those identified in 
this study, may be useful to alert health 
professionals about the importance of iden-
tifying and monitoring the elderly groups 
most vulnerable to polypharmacy.
Keywords: Polypharmacy. Aged. Pharma-
coepidemiology. Inappropriate drugs. 
Population-based survey. Cross-sectional 
studies.
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Resumo
Foi avaliado o uso de cinco ou mais me-
dicamentos (polifarmácia) e seus fatores 
associados por idosos do município de São 
Paulo. Realizou-se estudo transversal de 
base populacional: Estudo SABE – Saúde, 
Bem-estar e Envelhecimento, no ano de 
2006. A amostra foi composta por 1.115 
idosos com 65 anos e mais, que correspon-
diam a 422.377 indivíduos do Município de 
São Paulo. Utilizou-se regressão logística 
múltipla. A prevalência de polifarmácia foi 
de 36%. Sexo feminino (OR = 1,7; IC 95%: 1,0; 
2,9), idade igual ou superior a 75 anos (OR = 
1,9; IC 95%: 1,3; 2,7), maior renda (OR = 1,8; 
IC 95%: 1,2; 2,8), estar trabalhando (OR = 1,8; 
IC 95%: 1,1; 2,9), auto avaliação de saúde 
regular (OR = 1,6; IC 95%: 1,1; 2,3) ou ruim 
(OR = 2,6; IC 95%: 1,4; 4,9), hipertensão (OR 
= 2,0; IC 95%: 1,4; 2,9), diabetes (OR = 4,1; 
IC 95%: 2,2; 7,5), doença reumática (OR = 
2,3; IC 95%: 1,5; 3,6) e problemas cardíacos 
(OR = 2,9; IC 95%: 1,9; 4,5) apresentaram 
associação positiva com polifarmácia. Usar 
apenas o sistema público de saúde (OR = 
0,5; IC 95%: 0,3; 0,7) associou-se inversa-
mente à polifarmácia. Os medicamentos 
mais utilizados foram os de ação no sistema 
cardiovascular e trato alimentar e metabo-
lismo. No âmbito da farmacoepidemiologia, 
o conhecimento dos fatores associados a 
polifarmácia, como os identificados nesse 
estudo, pode ser útil para alertar os profis-
sionais da saúde quanto à importância de 
identificar e monitorar os grupos de idosos 
mais vulneráveis a polifarmácia. 
Palavras-chave: Polimedicação. Idoso. 
Farmacoepidemiologia. Estudo populacio-
nal. Medicamentos inapropriados. Estudo 
transversal.
Introduction
The concept of health proposed by the 
World Health Organization as complete 
physical, mental and social wellbeing and 
not merely the absence of illness may not 
be adequate for describing health for the 
elderly.1 An elderly individual is considered 
healthy when functionally capable, socially 
integrated and able to manage his/her own 
life in an independent fashion.
The ageing of the population is a phe-
nomenon seen throughout the world. In 
Brazil, the segment of the population aged 
60 years or older totaled 14.1 million in 2002 
and is expected to reach 33.4 million by 
2025.2 While this may be considered a major 
victory, it also constitutes a huge challenge. 
The increase in life expectancy leads to 
an increase in the number of individuals 
with non-transmissible chronic diseases 
(NTCDs), which require continuous care. 
Medications play an important role in this 
scenario, as a large percentage of elderly 
individuals use medications on a regular 
basis.3,4,5 The treatment protocol for various 
NTCDs involves the combination of several 
medications and the combined prescrip-
tions of an elderly individual with one or 
more NTCDs are likely to be classified as 
polypharmacy, which is the concomitant 
use of five or more medications.6,7 
In recent years, there has been a consi-
derable increase in geriatric polypharmacy. 
More than 40% of individuals aged 65 years 
or older take five or more medications per 
week and 12% take ten different agents.7 
Elderly individuals take a disproportional 
number of prescription medicines; appro-
ximately one third purchase medications 
from more than one drugstore and half 
receive prescriptions from more than one 
prescriber.8 The number of medications, 
complexity of therapeutic regimens (espe-
cially in the presence of co-morbidities) and 
the pharmacokinetic and pharmacodyna-
mic changes inherent to the ageing process 
are elements that increase the vulnerability 
of this age group to adverse drug events due 
to either adverse reactions or drug-drug 
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interactions.9 Adverse drug events can com-
promise the functional capacity of elderly 
individuals exposed to polypharmacy and 
also constitute excess cost to the healthcare 
system.10 Thus, medications can contribute 
to preserving functional capacity, but can 
also compromise it. Therefore, the risk-
-benefit of medications prescribed to elderly 
individuals must be evaluated adequately.
The aim of the present study was to 
quantify the use of polypharmacy (5 or more 
medications) and analyze factors associated 
with this practice among elderly residents of 
the city of São Paulo (Brazil). 
Methods
Population surveyed 
A population-based cross-sectional 
study, entitled the Saúde, Bem-Estar e 
Envelhecimento (SABE [Health, Wellbeing 
and Ageing]) study, was carried out with in-
dividuals aged 60 years or older who resided 
in metropolitan São Paulo in 2000.11 
The intentional probabilistic cluster 
sample was comprised of two segments: the 
first, resulting from randomized selection by 
lots, corresponded to 1,568 individuals and 
the second was made up of 575 residents in 
districts in which the previous interviews 
were held. The latter segment corresponded 
to an increase applied to compensate for 
the mortality rate of the population over 75 
years of age and achieve the desired number 
of interviews in this age group. Thus, infor-
mation on 2,143 individuals was obtained. 
To ensure the representativeness of the 
population, the sample size was calculated 
adjusting for gender, age group and socio-
economic status. Based on this calculation, 
sample weights were attributed to enable 
the analysis of a complex sample. Further 
details on the sample selection procedure 
are presented by Lebrão and Duarte.11 
In 2006, the SABE study became lon-
gitudinal as the first follow up of the po-
pulation surveyed in 2000 was performed. 
Data from the São Paulo State Data Analysis 
System, which analyzes economic, social 
and demographic data from the state of 
São Paulo, and the Mortality Information 
Program, which collects and analyzes mor-
tality data in the city of São Paulo, were used 
to identify individuals who died between 
2000 and 2006. Among the individuals inter-
viewed in 2000, 1,115 were re-interviewed in 
2006. Losses were due to deaths (649), refu-
sals to participate (177), change in address 
(51), institutionalizations (12) and failure to 
locate individuals (139). Participants of the 
sample of the present study were 65 years 
or older at the time.
Variables 
The 2006 SABE questionnaire had 15 
sections addressing aspects related to the 
life of the elderly individual, such as perso-
nal information, health status, functional 
status, cognitive evaluation, use and access 
to health services and medications, family 
support, work history, sources of income, 
housing characteristics, anthropometrics, 
flexibility and mobility. The questionnaire 
is available at http://www.fsp.usp.br/sabe. 
The variable of interest was polyphar-
macy, which is defined herein as the use of 
five or more medications. Polypharmacy 
was determined based on the answers to 
the following questions: “Can you show 
me the medications that you are currently 
taking?” and “Can you tell me the names 
of the medications you take?” Associations 
were determined between polypharmacy 
and socio-demographic variables, clinical 
variables, access to health services and 
self-reported health conditions extracted 
from personal information, health status, 
medications, access to health services, work 
history and sources of income sections 
of the questionnaire. Chart 1 displays the 
variables included in the analysis. 
Medications were classified based on 
the Anatomical Therapeutic Chemical (ATC) 
classification system,12 which is divided into 
five levels, the first of which is subdivided 
into 14 main anatomical groups. Levels 2 
and 3 correspond to therapeutic/pharma-
cological subgroups. Level 4 represents the 
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therapeutic/pharmacological/chemical 
group and Level 5 represents chemical 
substances. In the present study, Level 5 was 
used to classify the medications. 
Data analysis 
For the descriptive analysis, mean and 
standard error values were estimated for 
continuous variables and proportions 
were estimated for categorical variables. 
Differences between groups were determi-
ned using the Wald test of mean equality and 
the Rao-Scott test,13 which considers sample 
weights for the estimate of population wei-
ghts. Logistic regression analysis with the 
forward stepwise method was performed 
in the evaluation of factors associated with 
polypharmacy, in which variables with a 
p-value < 0.20 in the univariate analysis 
were selected, maintaining those that re-
mained significant (p < 0.05) or adjusted the 
estimation measure (OR) by at least 10%. 
Inferences took into account the sampling 
weights of the study design. Data analysis 
was performed using the Stata® statistical 
package (version 11).14 Values of variables 
that did not obtain a response (missing 
data) were excluded from the analysis. To 
avoid response bias regarding self-reported 
items, responses were excluded from the 
analysis when an individual exhibited an 
inability to answer, as measured by objective 
evaluations present in the questionnaire. 
The present study received appro-
val from the Human Research Ethics 
Committee of the School of Public Health of 
the University of São Paulo (Process num-
ber: 67/99) and the National Research Ethics 
Committee (Project number: 315/99). All 
interviewees or proxies signed a statement 
of informed consent. There are no conflicts 
of interest related to this study.
Chart 1 - Definitions, references and contrasts of independent variables used to analyze the practice of polypharmacy 
among elderly residents in São Paulo - SABE Study, 2006
Quadro 1 – Definições, referências e contrastes das variáveis independentes utilizadas na análise do uso de polifarmácia por 
idosos residentes no Município de São Paulo – Estudo SABE, 2006.
Variables Definition Reference Contrast
Age In years 65 to 74 years ≥ 75 years
Gender Male Female
Terciles of income Income of individual in relation to minimum 
salary
Schooling Year of study completed No schooling ≥ 1 year of study
Work status Currently working Active Inactive
Living arrangement Lives alone or with others Alone With others
Health coverage Has health insurance beyond public 
healthcare
Private Public
Self-rated health Self-reported health status Excellent Fair, poor/very poor
Hospitalization in previous 
year
Self-reported hospitalization in previous year None 1 or more
Hypertension Self-reported hypertension No Yes
Diabetes Self-reported diabetes No Yes
Lung disease Self-reported lung disease No Yes
Rheumatic disease Self-reported rheumatic disease No Yes
Heart disease Self-reported heart disease No Yes
Fall in previous 12 months Self-reported fall in previous 12 months No Yes
Cancer Self-reported cancer No Yes
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Results
Among the 1,115 elderly individuals of 
the baseline cohort of the SABE study and 
who were re-interviewed in 2006, 999 were 
users of medications, corresponding to 
422,377 individuals aged 65 years or older 
in the city of São Paulo. The number of 
medications in this group ranged from one 
to 16, with a mean of 3.6 medications per 
individual. 
The majority was 75 years or age or 
older (83.6%), female (63.0%), had studied 
between one and six years (64.2%), did not 
work (79.1%), did not live alone (84.1%) and 
had not been hospitalized in the year prior 
to the survey (87.8%). Approximately half 
had private health insurance (49.4%) and 
self-rated their health as either excellent 
(41.5%) or fair (48.6%). Regarding diseases, 
67.8% reported having hypertension, 23.6% 
reported having diabetes, 10.6% reported 
having lung disease, 36.4% reported having 
rheumatic disease and 25% reported having 
heart disease. Approximately half the sam-
ple (49.7%) reported having fallen in the 12 
months prior to the interview. 
Thirty-six percent of the interviewees, 
representing 151,902 elderly individuals, 
reported taking five or more medications. 
The following variables were significantly 
associated with polypharmacy (p < 0.05): 
age, gender, working status, type of health 
coverage, self-rated health, hospital admis-
sion in the previous year, hypertension, 
diabetes, rheumatic disease, lung disease 
and heart disease (Table 1). The multiple 
regression analysis revealed that the follo-
wing factors remained positively associated 
with polypharmacy: female gender; age over 
75 years; higher income; health self-rated 
as fair and poor/very poor; self-reported 
hypertension, diabetes, rheumatic disea-
se and heart disease; and being currently 
Table 1 - Association between polypharmacy, socio-demographic variables and indicators of health status among 
elderly residents in São Paulo - SABE Study, 2006
Tabela 1 - Associação entre polifarmácia, variáveis sociodemográficas e indicadores de condição de saúde da população 
idosa residente no Município de São Paulo – Estudo SABE, 2006.
Variables
Medications
OR (95% CI) p
1 - 4 (%) ≥ 5 (%)
Age
65 to 74 years 65.7 34.3 1.0
75 years or older 55.7 44.3 1.5 (1.1 – 2.0) 0.004
Gender
Male 72.0 28.0 1.0
Female 59.4 40.6 1.8 (1.2 – 2.6) 0.005
Terciles of income (x MS)
1 (0.03 – 1.30) 69.5 30.5 1.0
2 (1.31 – 2.71) 61.0 39.0 1.5 (1.0 – 2.2) 0.057
3 (2.72 – 42.85) 62.8 37.2 1.3 (0.9 – 1.9) 0.090
Schooling (years)
0 63.4 36.6 1.0
1 to 3 68.8 31.2 0.8 (0.5 – 1.3) 0.339
4 to 11 62.4 37.6 1.0 (0.6 – 1.7) 0.859
12 to 22 55.1 44.9 1.4 (0.6 – 3.1) 0.380
Work status
Active 73.8 26.2 1.0
Inactive 61.6 38.4 1.8 (1.1 – 2.7) 0.010
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Variables
Medications
OR (95% CI) p
1 - 4 (%) ≥ 5 (%)
Living arrangement
Lives alone 62.7 37.3 1.0
Lives with others 64.2 35.8 0.9 (0.6 – 1.4) 0.743
Health coverage
Private 56.3 43.7 1.0
Public 71.6 28.4 0.5 (0.4 – 0.7) 0.000
Self-rated health
Excellent 73.00 27.00 1.0
Fair 60.8 39.2 1.7 (1.3 – 2.4) 0.001
Poor/very poor 44.0 56.0 3.4 (2.0 – 6.0) 0.000
Hospitalization in previous year
None 66.7 33.3 1.0
One or more 45.0 55.0 2.4 (1.6 – 3.7) 0.000
Hypertension
No 77.7 22.3 1.0
Yes 57.5 42.5 2.6 (1.8 – 3.6) 0.000
Diabetes 
No 71.6 28.4 1.0
Yes 38.8 61.2 4.0 (2.7 – 5.8) 0.000
Lung disease 
No 65.5 34.5 1.0
Yes 52.9 47.1 1.7 (1.1 – 2.7) 0.024
Rheumatic disease 
No 72.1 27.9 1.0
Yes 50.1 49.9 2.6 (1.9 – 3.5) 0.000
Heart disease
No 71.4 28.6 1.0
Yes 41.3 58.7 3.6 (2.5 – 5.1) 0.000
Fall in previous 12 months
No 59.4 40.6 1.0
Yes 57.2 42.8 1.1 (0.8 – 1.5) 0.598
Cancer
No 64.4 35.6 1.0
Yes 58.0 42.0 1.3 (0.7 – 2.3) 0.342
SM = salário mínimo nacional vigente à época da pesquisa = R$ 350,0028
MS = national minimum salary at time of survey = R$ 35028
Table 1 - Association between polypharmacy, socio-demographic variables and indicators of health status among elderly 
residents in São Paulo - SABE Study, 2006 (continuation)
Tabela 1 - Associação entre polifarmácia, variáveis sociodemográficas e indicadores de condição de saúde da população 
idosa residente no Município de São Paulo – Estudo SABE, 2006 (continuação)
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Table 2 - Factors associated with polypharmacy (use of five or more drugs) among elderly 
residents in São Paulo after multivariate regression analysis - SABE Study, 2006
Tabela 2 – Fatores associados com polifarmácia (uso de 5 ou mais medicamentos) entre idosos 
residentes no Município de São Paulo após análise de regressão múltipla – Estudo SABE, 2006.
Variables Adjusted OR* (95% CI) p-value
Age (75 years or more) 1.9 (1.3 – 2.7) 0.001
Female gender 1.7 (1.0 – 2.9) 0.036
2nd tercile of income 1.3 (0.8 – 2.2) 0.219
3rd tercile of income 1.8 (1.2 – 2.8) 0.008
Work status (active) 1.8 (1.1 – 2.9) 0.020
Health coverage (public system) 0.5 (0.3 – 0.7) 0.001
Health self-rated as fair 1.6 (1.1 – 2.3) 0.021
Health self-rated as poor/very poor 2.6 (1.4 – 4.9) 0.003
Hospitalization in previous year 1.7 (1.0 – 2.9) 0.059
Hypertension 2.0 (1.4 – 2.9) 0.000
Diabetes 4.1 (2.2 – 7.5) 0.000
Rheumatic disease 2.3 (1.5 – 3.6) 0.000
Heart disease 2.9 (1.9 – 4.5) 0.000
*OR ajustado por 2º tercil de renda e internação no último ano.
*OR adjusted for 2nd tercile of income and hospital admission in previous year
Table 3 – The 20 drugs most used by elderly individuals practicing polypharmacy (5 or more 
medications) according to ATC* Classification, city of São Paulo, SABE Study, 2006
Tabela 3 - Os 20 medicamentos mais utilizados pelos idosos usuários de polifarmácia (5 ou mais 
medicamentos), segundo a Classificação ATC *, Município de São Paulo, Estudo SABE, 2006.
Medications ATC* classification (5th level) %
















Calcium carbonate and vitamin D A11AA02 1.03
Atorvastatin C10AA05 1.01
Paracetamol (acetaminophen) N02BE01 0.97
Diclofenac M01AB05 0.93
* Classificação Anatomical Therapeutic Chemical
* Anatomical Therapeutic Chemical Classification
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employed. Exclusive use of the public heal-
thcare system was associated with a lower 
number of medications (Table 2). Among 
the 20 medications most often used by the 
individuals with polypharmacy, 10 (50%) 
acted on the cardiovascular system (Groups 
B and C – AAS). The second most frequent 
class was of medications acting on the 
alimentary tract and metabolism (Group 
A) (Table 3). 
Discussion
Taking five or more medications was 
reported by 36% of the elderly individuals. 
This finding may have several explanations. 
To a certain extent, it is the consequence of 
the higher prevalence of NTCDs in this age 
group. Another aspect is the fact that elderly 
individuals are often treated by different spe-
cialists within a short span of time without 
being asked what drugs are currently in use, 
which contributes to the use of multiple 
medications. Moreover, prescriptions are 
often filled repeatedly because patients are 
not oriented with regard to the duration of 
treatment.15 At times, adverse reactions to 
medications are mistakenly interpreted as 
new clinical conditions and treated with new 
agents, thereby constituting an iatrogenic 
cascade.16 Advertising directed at consumers 
also contributes to polypharmacy by increa-
sing the demand for particular medications 
and encouraging self-medication.17 
The prevalence of polypharmacy in the 
present study was greater than that reported 
in other population-based studies carried 
out in Brazilian elderly individuals that also 
define this phenomenon as the use of five 
medications or more. Previous studies re-
port prevalence values ranging from 14.3% 
in metropolitan Belo Horizonte18 to 27% in 
the city of Porto Alegre19 and 32.7% among 
retirees in Rio de Janeiro.10 These differences 
may be related to the characteristics of the 
populations surveyed and the methodo-
logy employed in the different inquiries.8 
For example, a large portion of the present 
sample was made up of individuals aged 
75 years or older who took a greater mean 
number of medications than those in the 
aforementioned studies. 
The analysis of socio-demographic cha-
racteristics revealed an association between 
polypharmacy and the female gender, age 
over 75 years, greater income and being 
currently employed (Table 2). Previous 
studies also report the female gender to 
be associated with this practice.6,18,19,20,21 
Irrespective of polypharmacy, the reasons 
for the use of medications predominantly 
among elderly women may be linked to 
issues of a biological, psychological and 
socio-cultural nature, as women are more 
exposed to non-fatal health problems, worry 
more about physical symptoms, place grea-
ter focus on health problems, use healthcare 
services more often throughout life and are 
more familiar with medications.18 
With regard to age, polypharmacy was 
associated with the older age group (75 years 
or older). This finding is likely related to the 
greater occurrence of health problems in 
this age group, which are generally chronic 
and of greater severity.7,18,20 
Elderly individuals with a higher income 
took more medications. Previous surveys 
also report a positive association between 
higher income and the use of medications,3 
particularly polypharmacy.22 In contrast, 
the exclusive use of the public healthca-
re system was inversely associated with 
polypharmacy. These individuals may only 
use medications provided by the public 
healthcare system, which may limit the 
number of medications used. 
Polypharmacy was associated with 
current employment. Elderly individuals 
continuing in the job market depends on 
an adequate health status, which may be 
maintained, in part, by the use of medica-
tions that control NTCDs. 
Polypharmacy was associated with he-
alth self-rated as fair and poor/very poor, 
as reported in previous surveys carried out 
in Brazil18,21 and other countries.19,23 This 
finding was expected, as there is an obvious 
connection between health problems and 
the use of medications. Individuals who be-
come ill or perceive themselves as being ill 
825 Rev Bras Epidemiol2012; 15(4): 817-27
Polypharmacy among the elderly in the city of São Paulo, Brazil – SABE Study
Carvalho, M.F.C. et al.
seek a solution or relief for their symptoms 
through the use of medications.18
In agreement with a previous study on 
polypharmacy carried out in Brazil,10 the 
individuals in the present study who repor-
ted hypertension, diabetes, heart disease 
and rheumatic disease were more prone 
to polypharmacy. This finding was also 
expected, as these conditions are prevalent 
in the elderly population, the control of 
which generally requires several different 
medications. Moreover, elderly individuals 
often have several concomitant conditions, 
leading to the need for polypharmacy. 
Hospital admissions in the previous year 
were associated with polypharmacy, which 
is likely related to a poorer health status.
The list of the 20 most used medications 
among the individuals practicing polyphar-
macy (Table 3) reflects the most prevalent 
NTCDs. The most used medications were for 
the treatment of cardiovascular conditions 
(hypertension, coronary disease) and dia-
betes (particularly type 2). Two medications 
on this list (ranitidine and omeprazole) 
reduce gastric acid and are indicated for 
the treatment of conditions in which the 
physiopathology involves the secretion of 
gastric acid, such as peptic ulcers and reflux 
esophagitis. The wide (and not always ratio-
nal) prophylactic use of these medications 
has been documented, which may at least 
partially explain the high frequency of use 
in the present sample.24
The present study has limitations that 
should be addressed. Despite its inherent 
value, the cross-sectional design does not 
allow establishing the temporality of the 
associated factors. Thus, longitudinal stu-
dies involving the elderly participants of the 
SABE study are needed, and are currently 
underway. Another point that merits atten-
tion is that self-reported conditions may 
lead to the underestimation of the prevalen-
ce of disease due to problems of memory or 
even a lack of diagnosis. Elderly individuals 
may also overestimate their health status in 
order to demonstrate self-sufficiency due to 
a fear of requiring care or being institutiona-
lized. Some of the questionnaires were filled 
out by proxy, which may have affected the 
responses. Moreover, cultural differences 
associated with lower levels of schooling 
and income as well as lower expectations 
regarding the health status of elderly in-
dividuals may affect evaluations of health 
performed by a third-party informant.25 
The results of the present study demons-
trate that polypharmacy is highly prevalent 
among elderly individuals in the city of São 
Paulo, which may lead to serious conse-
quences for this age group. Considering the 
particularities of the geriatric population 
with regard to the prevalence of NTCDs and 
respective treatments, to take into account 
the number of medications as the only pa-
rameter for the assessment of pharmacothe-
rapy among the elderly may be inadequate 
from the standpoint of public health. It is 
necessary to assess the suitability of what 
is being used in terms of both the choice 
of medications and dosages.9,26 It should 
be stressed that individuals in the elderly 
population come from very heterogeneous 
groups with regard to functional capacity, 
which is the result of a complex interaction 
of multiple factors, such as genetics, lifesty-
le, past illnesses, the quality of healthcare, 
etc. Thus, functional capacity can be very di-
fferent between two individuals of the same 
age and gender.27 Likewise, the intensity of 
the pharmacokinetic and pharmacodyna-
mic alterations that accompany the ageing 
process and the consequences of polypha-
ramacy can differ considerably between 
individuals. Prescribers need to consider 
this variability when selecting medications 
and dosages so that the functional capacity 
of elderly patients is not compromised.9 The 
rational use of medications in the growing 
elderly population is a huge public health 
challenge. This complex issue involves the 
responsibility of all links in the medication 
chain – from the pharmaceutical industry, 
regulatory agencies and healthcare syste-
ms to health professionals and patients. 
Educational and administrative measures 
are needed to ensure quality drug therapy 
for the geriatric population. 
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